Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 29;12:125. doi: 10.1186/s13048-019-0601-6

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 5 — Kallistatin enhanced the platinum sensitivity of ovarian cancer cells. (A) Western blot analysis of kallistatin protein levels in A2780, A2780/DDP, A2780 and OVCAR3 cells treated with cisplatin at 0, 2, 4, and 8 μg/ml for 48 h. (B) Cell viability was determined using MTT in A2780, UWB1.289 and OVCAR3 cells. (C) The proportion of apoptotic cells was measured by Annexin V-FITC/PI staining and flow cytometry after cisplatin (CDDP) treatment for 24 h. (D) Western blot analysis of apoptosis-related proteins. *p < 0.05, **p < 0.01, ***p < 0.001